We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TEAD:NASDAQTeads Holding Co. Analysis

Data as of 2026-05-04 - not real-time

$0.92

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Teads Holding Co. (TEAD) is trading at $0.92, comfortably above its 20‑day (0.77) and 50‑day (0.75) simple moving averages but still below the 200‑day SMA (1.17), indicating short‑term momentum in a longer‑term downtrend. The RSI sits at 64, the MACD line is bullish (+0.051) and the price is approaching the identified resistance near $0.96, while a solid support zone sits around $0.60, suggesting limited downside in the near term. Market sentiment is highly optimistic, with the Fear & Greed Index at 88 (Extreme Greed) and an upside potential of roughly 9% versus a similar downside risk.
Fundamentally, TEAD shows strong top‑line growth (+50% YoY revenue) but is hampered by thin gross margins (33%) and a negative operating margin (-0.2%). The company posts a sizable net loss (trailing EPS -$5.69) and negative free cash flow, while carrying a heavy debt load ($654 M) versus modest cash ($139 M), resulting in an astronomical debt‑to‑equity ratio (>600). High volatility (84% 30‑day) and a beta well above market (~2.8) amplify the risk, and the stock’s liquidity is thin given its low market cap and trading volume.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD and RSI indicating short‑term momentum
  • Proximity to resistance level limiting upside
  • High volatility and thin trading volume

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong revenue growth but persistent losses
  • Heavy debt burden increasing financial risk
  • Price-to-sales (0.07) and price-to-book (0.92) suggest valuation headroom

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Negative earnings and cash flow trends
  • Elevated leverage and weak profitability metrics
  • Sustained high beta and volatility indicating price instability

Key Metrics & Analysis

Financial Health

Revenue Growth50.20%
Profit Margin-39.76%
P/E Ratio-1.6
ROE-316.46%
ROA-1.06%
Debt/Equity684.73
P/B Ratio0.9
Op. Cash Flow$7.6M
Free Cash Flow$-25426376
Industry P/E18.8

Technical Analysis

TrendNeutral
RSI64.2
Support$0.60
Resistance$0.96
MA 20$0.77
MA 50$0.75
MA 200$1.17
MACDBullish
VolumeStable
Fear & Greed Index88.34

Valuation

Target Price$1.00
Upside/Downside8.97%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.76
Volatility83.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.